Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azelastine Nasal Spray for COVID-19
DRKS00024520Phase 2Completed
- Sponsor
- URSAPHARM
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of azelastine in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by URSAPHARM. Started Feb 2021; status: completed.
02
Drugs
azelastine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on DRKS00024520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00024520.